Rapid purification of bovine kidney branched-chain 2-oxoacid dehydrogenase complex containing endogenous kinase activity  by Lawson, Rowena et al.
Volume 157, number 1 FBBS 0495 June 1983 
Rapid purification of bovine kidney branched-chain 2-oxoacid 
dehydrogenase complex containing endogenous kinase activity 
Rowena Lawson, Kenneth G. Cook and Stephen 3. Yearnan* 
apartment of Biochemistry, Rid~ey B~iid~~g, The University, Newcastle upon Tyne NEi 7RU, England 
Received 12 April 1983 
Branched-chain 2-oxoacid ehydrogenase compIex has been purified to near homogeneity by a simple, 
rapid procedure. The final product contains endogenous kinase activity capable of phosphorylating and 
inactivating the compIex. Phosphorylation continues after complete inactivation, indicating the possibility 
of several phosphorylatabte sites. 
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1. INTRODUCTION 
Mitochondria of mammalian tissues contain 3 
distinct 2-oxoacid dehydrogenase multi-enzyme 
complexes which catalyse the oxidative decarbox- 
ylation of pyruvate, 2-oxoglutarate and the bran- 
ched chain 2-oxoacids. Each complex consists of 3 
enzyme components, a 2-oxoacid dehydrogenase 
(El), a dihydrolipoyl transacylase (Ez) and a 
dihydrolipoyl dehydrogenase (Es) which catalyse 
consecutive steps in the overall reaction [l]. 
Branched-chain 2-oxoacid dehydrogenase com- 
plex oxidises the 2-oxoacids derived from the 
essential amino acids leucine, isoleucine and 
valine. Studies have been done on the enzyme com- 
plex from a variety of tissues, including kidney, 
liver, heart, skeletal muscle and adipose tissue 
(reviewed [2]). Evidence was first obtained by 
Parker and Randle [3] that the activity of the en- 
zyme is regulated by covalent phosphorylation, the 
enzyme being inactivated by phosphorylation. This 
has been substantiated by various studies using 
perfused heart [4,51, isolated mitochondria [6] and 
enzyme preparations [7-91. 
The enzyme complex was first purified to ap- 
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parent homogeneity from bovine kidney 
mitochondria in [lo]. However, unlike the 
pyruvate dehydrogenase complex which is also 
regulated by phosphorylation, the final product 
did not contain endogenous kinase activity. Subse- 
quently, methods have been reported for the 
purification from bovine kidney [S] and rat kidney 
[9] mitochondria of branched-chain 2-oxoacid 
dehydrogenase complex associated with a kinase 
activity capable of phosphorylating and inac- 
tivating the complex. 
Traditionally, methods for purification of the 
2-oxoacid dehydrogenase complexes have involved 
preparation of mitochondria, disruption of these 
mitochondria and subsequent purification of the 
complexes from the mitochondri~ extract. Stanley 
and Perham [l l] first reported a method for 
purification from bovine heart of the pyruvate and 
2-oxoglutarate dehydrogenase complexes which in- 
volves disruption of tissue in the presence of Triton 
X-100 and subsequent purification of the enzymes 
from the whole extract, without the need to 
prepare mitochondria. 
Here, we report a procedure for the rapid, large- 
scale purification, to apparent homogeneity, of the 
branched-chain 2-oxoacid dehydrogenase complex 
from bovine kidney cortex, without the require- 
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ment of isolating mitochondria. The final product 
contains an endogenous kinase, which in the 
presence of ATP-Mg, phosphorylates the a- 
subunit of the Ei component, inactivating the com- 
plex against its 3 branched-chain 2-oxoacid 
substrates. 
2. MATERIALS AND METHODS 
Branched-chain 2-oxoacids and antifoam A con- 
centrate were from Sigma; Triton X-100 and 
polyethylene glycol 6000 from BDH Chemicals; 
hexokinase (yeast) from Boehringer; hydrox- 
ylapatite HTP from BioRad Labs. [y-32P]ATP was 
synthesised as in [12], or purchased from Amer- 
sham International. 
Branched-chain 2-oxoacid dehydrogenase com- 
plex was assayed at 30°C in the presence of excess 
dihydrolipoyl dehydrogenase [lo]. One unit of en- 
zyme catalyses the formation of 1 pm01 
NADH/min. Protein was determined by a scaled- 
down version of the Bradford [13] or Lowry 
method [14] following precipitation of the protein 
using trichloroacetic acid. 
Polyacrylamide gel electrophoresis in the 
presence of sodium dodecyl sulphate 
(SDS-PAGE) was done essentially as in [ 151. The 
running gel contained 10% (w/v) acrylamide and 
the stacking gel 5%. Staining was with Coomassie 
brilliant blue R and the gels were dried prior to 
autoradiography. Scanning of the gels and 
autoradiographs was done using a Joyce Loebl 
Chromoscan 3. 
Correlation of phosphorylation with inactiva- 
tion was carried out as in [16]. Branched-chain 
2-oxoacid dehydrogenase complex was incubated 
at 20°C in buffer C containing 10 mM MgClz; 
0.5 mM [Y-~~P]ATP and 4 /cg oligomycin B/ml. At 
intervals aliquots were removed and phosphoryla- 
tion in these aliquots was terminated by addition 
of 0.1 vol. 1 M glucose and 0.01 vol. 10 mg hex- 
okinase/ml. The aliquots were then assayed for 
branched-chain 2-oxoacid dehydrogenase activity, 
protein-bound [32P]phosphate [17] and analysed 
by SDS-polyacrylamide gel electrophoresis and 
autoradiography. 
Buffer A consists of 50 mM potassium 
phosphate, 2 mM EDTA, 3% (v/v) Triton X-100, 
1 mM benzamidine, 1 mM PMSF, 0.1 mM DTT 
(pH 7.5); buffer B is 30 mM potassium phosphate, 
0.1 mM EDTA, 0.1 mM EGTA, 1 mM benz- 
amidine, 1 mM PMSF, 1 mM DTT (pH 7.3); buf- 
fer C is 30 mM sodium phosphate, 0.1 mM ED- 
TA, 0.1 mM EGTA, 1 mM benzamidine, 1 mM 
PMSF, 1 mM DTT (pH 7.3). 
3. RESULTS 
3.1. Purification of branched-chain 2-oxoacid 
dehydrogenase complex 
Ox kidney was obtained within 10 min of 
slaughter and transported on ice to the laboratory. 
All subsequent operations were carried out at 4°C. 
Cortex (-250 g) was removed, finely chopped and 
then homogenised in a blender for 3 min in 2 vol. 
buffer A containing antifoam A (0.5 ml/l). After 
homogenisation an equal volume of buffer A was 
added and the homogenate was centrifuged at 
26000 x g for 15 min. The resulting supernatant 
had pH -7.3. 
To this supernatant was added 0.12 vol. 
polyethylene glycol (35070, w/v), the mixture was 
stirred for 30 min, and the resultant precipitate 
was collected by centrifugation at 30000 x g for 
15 min. The precipitate was resuspended in buffer 
B (l/3 initial vol.), resuspension being completed 
by treating the sample with a Polytron PTlOS at 
setting 2 for 20 s. The mixture was stirred for 
30 min (PEG I) and then clarified by centrifuga- 
tion at 30000 x g for 30 min (PEG I clarified). 
This first precipitation step is crucial as it removes 
most of the 2-oxoglutarate dehydrogenase and 
pyruvate dehydrogenase complexes, the remainder 
of these complexes being removed at subsequent 
stages of the purification procedure. 
To the clarified solution was then added 
0.12 vol. polyethylene glycol and after stirring for 
30 min the precipitate was again collected by cen- 
trifugation at 30000 x g for 15 min. The 
precipitate was resuspended in buffer B (l/20 in- 
itial vol.), and homogenised, stirred (PEG II) and 
clarified (PEG II clarified) as above. 
The clarified material was applied to hydrox- 
ylapatite (2.6 x 6 cm) pre-equilibrated in buffer B. 
This was washed extensively with buffer B contain- 
ing 200 mM potassium phosphate until the absor- 
bance at 280 nm of the eluant decreased to zero. 
The branched-chain 2-oxoacid dehydrogenase 
complex was then eluted using buffer B containing 
350 mM potassium phosphate. Fractions contain- 
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ing enzyme activity were pooled and further 
purified and concentrated by centrifugation at 
180000 x g for 3.5 h. The final pellet was carefully 
resuspended in buffer C. 
A typical purification is summarised in table 1. 
Because of the high levels of Triton X-100 and the 
presence of competing activities it is not possible to 
determine accurately the branched-chain 2-oxoacid 
dehydrogenase activity in the 1st supernatant. The 
whole procedure can be completed within 1.5 
working days. A convenient stopping point at the 
end of day 1 is to load the PEG II clarified fraction 
onto hydroxylapatite and to wash the column over- 
night with buffer B containing 200 mM potassium 
phosphate. All centrifugation steps (except the 
180000 x g spin) can be carried out in one 6 x 
300 ml rotor (e.g., Beckman JA-14). The pro- 
cedure can be scaled up several fold without any 
significant increase in preparation time. If larger 
quantities of tissue are being processed it is conve- 
nient to use a larger-capacity rotor and lower 
gravitational forces (e.g., 10000 x g) to obtain the 
1st supernatant fraction. No changes in the subse- 
quent purification steps are necessary. 
3.2. Characterisation of the purified complex 
Analysis of the final material by 
SDS-polyacrylamide gel electrophoresis indicates 
that the complex is essentially homogeneous 
(fig.1). The 3 protein bands corresponding to Et 
and the a- and &subunits of El, constitute > 90% 
of the stainable protein, the remainder being 
several minor bands of higher-iK. In agreement 
with [8,10] the purified complex is devoid of the E3 
component. 
The specific activity of the final material, using 
3 methyl 2-oxobutyrate as substrate, was 
-3.4 U/mg, this value ranging from 1.5-5.0 for 
several different preparations of enzyme. This is 
lower than the highest reported value of 11.8 [lo]. 
The reasons for this difference are not clear 
although one possibility is that homogenisation in 
the presence of Triton causes some irreversible in- 
activation of the complex. The purified complex is 
active against all 3 branched-chain 2-oxoacids, 
namely 3-methyl 2-oxobutyrate, 4-methyl 
2-oxopentanoate and 3-methyl2-oxopentanoate in
the ratio 2 : 1.4: 1 .O and also has some activity 
(0.06) against pyruvate but is completely devoid of 
activity against 2-oxoglutarate. 
A key feature of the purification method 
described here is that the purified complex con- 
tains an endogenous kinase activity. In the 
presence of ATP-Mg this phosphorylates the cy- 
subunit of the El component (fig.1). Under these 
conditions no other component becomes 
phosphorylated. Phosphorylated is accompanied 
by loss of activity against all 3 branched-chain 
2-oxoacids, the 3 activities being lost concurrently 
(fig.2). As judged by the time required to half- 
inactivate the complex, there is no significant loss 
of kinase activity from the complex during the 
purification procedure. 
Fig.2 indicates that phosphorylation continues 
after complete inactivation of the complex is 
achieved. One possible explanation of this is the 
Table 1 
Purification of branched-chain 2-oxoacid dehydrogenase complex 
Fraction Vol. 
(ml) 
Total act. 
W) 
Protein 
(mg) 
Spec. act. 
Wmg] 
Yield 
(Qo) 
1st Supernatant 980 - 21560 - 
PEG I 300 128 3300 0.039 100 
PEG I clarified 265 68 1670 0.041 53 
PEG II 60 63 670 0.094 49 
PEG II clarified 51 38 280 0.136 30 
Hydroxylapatite 27.5 33 25.6 1.29 26 
180000 x g pellet 2.2 23 6.8 3.38 18 
Starting material was 194 g kidney cortex. Activity was measured using 3-methyl 2-oxobutyrate as 
substrate. Protein was determined as in [13], except in the 1st supernatant fraction where, because of the 
presence of Triton X-100, the modified Lowry method [14] was used 
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Fig. 1. SDS-polyacrylamide gel electrophoresis of 
purified branched-chain 2-oxoacid dehydrogenase 
complex: (A) densitometric scan of autoradiograph of 
sample phosphorylated using [y-“P]ATP-Mg; (B) 
densitometric scan of protein stain of sample. 
1 100 
T -8Oy 
0 
‘iJ 
-60 z 
b 
c 
-40 Q 
E 
-20 s 
I 
Oo 
I I I I 
5 10 15 20 O 
Time(mid 
Fig.2. Phosphorylation and inactivation of purified 
branched-chain 2-oxoacid dehydrogenase complex: 
purified complex (10 U/ml) in buffer C was incubated 
with [y-“P]ATP-Mg (3.5 x 104 cpm/nmol) and treated 
as in section 2. Inactivation using as substrate: 3-methyl 
2-oxobutyrate (0); 4-methyl 2-oxopentanoate (A); 
3-methyl 2-oxopentanoate (0); and protein-bound 
phosphate (0). The maximum phosphorylation value 
corresponds to -5 nmol [32P]phosphate/mg protein, 
representing -0.8 mol phosphate/m01 a-subunit. 
presence of several phosphorylation sites on the 
enzyme, inactivation resulting from the rapid 
phosphorylation of one such site. Evidence in sup- 
port of multi-site phosphorylation comes from 
high-voltage electrophoresis of tryptic digests of 
phosphorylated complex, which indicates the 
presence of 3 distinct phosphopeptides [ 191. 
4. DISCUSSION 
The simple purification scheme reported here 
has several advantages over procedures. A major 
advantage over the method in [lo] is that the final 
preparation contains intrinsic kinase activity 
capable of phosphorylating and inactivating the 
branched-chain 2-oxoacid dehydrogenase com- 
plex. In the final preparation only one polypep- 
tide, namely the a-subunit of the Er component, 
can be phosphorylated. This makes the method ex- 
tremely useful for obtaining purified enzyme to 
study, in detail, the regulation of the complex by 
phosphorylation. The second advantage is that the 
purification method is rapid, allowing purified en- 
zyme to be prepared within 1.5 working days, and 
is capable of being scaled-up several fold. The 
yield of > 11 U activity/100 g tissue compares 
favourably with the highest yield (4.1 U/100 g) 
reported in [lo]. A method for obtaining highly 
purified complex from mitochondrial extracts with 
intrinsic kinase activity was reported in [8]. The 
specific activity of the final product was not deter- 
mined but the yield of 0.9 U/100 g cortex is 
lo-fold lower than reported here. In [18], a method 
has been reported for purification of the complex 
from Triton extracts of rabbit liver. However, the 
method is considerably slower than that reported 
here and the level of kinase in the final complex is 
very low, incubation for 80 min at 37°C being 
necessary to achieve complete inactivation. 
The availability, in large amounts from a conve- 
nient source, of highly-purified complex with en- 
dogenous kinase activity will now allow detailed 
investigation of the number of phosphorylation 
sites and their possible effect on enzyme activity. 
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